CD2 and systemic lupus erythematosus: Specifically, NPs better protected lupus mice when concomitantly targeted to CD4+ and CD2+ cells, being the suppressive activity on autoantibody production and disease manifestations superior to the sum of the activities deriving from CD4+ and CD8+ Tregs (10).